Metastatic uveal melanoma is a rare disease with a poor prognosis. Usual treatments have not proven effective. Tebentafusp, a bispecific protein targeting melanoma cells and T lymphocytes, is the first approved treatment with a proven survival benefit in a randomized clinical.
View Article and Find Full Text PDFPurpose: TRK fusions are detected in less than 2% of central nervous system tumors. There are limited data on the clinical course of affected patients.
Experimental Design: We conducted an international retrospective cohort study of patients with TRK fusion-driven CNS tumors.
Background: Dorsomedian nasopharyngeal masses with benign macroscopic appearance are frequently observed during retrograde nasopharyngoscopy, particularly in brachycephalic breeds, but are not well described.
Hypothesis/objectives: To characterize these masses, assess their frequency, and identify the potential factors associated with their presence.
Animals: Dogs that underwent retrograde nasopharyngoscopy at a private hospital.
Aliment Pharmacol Ther
December 2024